Ledger.Open graph →
SEC Form D · filed April 1, 2016

BIO BLAST PHARMA LTD

Offering
$6.7M
Sold
$6.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW HAVEN, CT
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Paul Firuta · New Haven, CTExecTheresa M. Stevens · New Haven, CTExecRobert Cook · Calgary, Alberta, CanadaExecDalia I. Megiddo · New Haven, CTDirectorWarren Wasiewski · New Haven, CTExecMichael M. Burshtine · New Haven, CTDirectorLeigh M. Cherry · New Haven, CTExecFredric Price · London, United KingdomExec · DirectorRan Nusbaum · TEL AVIV, L3DirectorThomas I. Dubin · New Haven, CTDirectorIsaac I. Krymolowski · New Haven, CTDirectorUdi Gilboa · TEL AVIV, L3DirectorColin Foster · New Haven, CTExec · DirectorGili M. Cohen · New Haven, CTDirectorMarlene Haffner · TEL AVIV, L3DirectorPaul Firuta · New Haven, CTExecTheresa M. Stevens · New Haven, CTExecRobert Cook · New Haven, CTExecDalia I. Megiddo · New Haven, CTDirectorWarren Wasiewski · New Haven, CTExecMichael M. Burshtine · New Haven, CTDirectorLeigh M. Cherry · New Haven, CTExecFredric Price · TEL AVIV, L3Exec · DirectorRan Nusbaum · TEL AVIV, L3DirectorThomas I. Dubin · New Haven, CTDirectorIsaac I. Krymolowski · New Haven, CTDirectorUdi Gilboa · TEL AVIV, L3DirectorColin Foster · New Haven, CTExec · DirectorGili M. Cohen · New Haven, CTDirectorMarlene Haffner · TEL AVIV, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗